Argentina Specialized Nutrition Market (2025 - 2033) Size, Share & Trends Analysis Report By Route of Administration, By Product (Powder, Pills, Liquid), By Application, By Sales Channel, By Module, By Region, And Segment Forecasts

Argentina Specialized Nutrition Market Summary

The argentina specialized nutrition market size was estimated at USD 229.6 million in 2024 and is projected to reach USD 372.0 million by 2033, growing at a CAGR of 7.4% from 2025 to 2033. This growth is attributed to the growing burden of chronic conditions such as cancer, diabetes, renal diseases, and gastrointestinal disorders, coupled with demographic trends like an aging population and pediatric nutritional challenges.

Healthcare professionals emphasize the role of nutrition as an adjunctive therapy, particularly in surgical recovery protocols, malnutrition management, and the care of metabolic diseases. Products with strong clinical evidence, easy-to-administer forms (oral and enteral), and compatibility with hospital nutrition guidelines tend to see higher adoption.

Increasing awareness among clinicians about the benefits of early nutritional intervention, supported by educational initiatives from key suppliers such as Danone, Abbott, and Fresenius SE & Co. KGaA, further promotes adoption. Patient compliance factors, such as palatability and formulation tolerability, particularly in pediatric and elderly populations, also influence prescribing patterns.

Chronic Disease Prevalence: Diabetes in Argentina

Source: International Diabetes Federation

Diabetes prevalence in Argentina is remarkably high and growing, with over 4.3 million adults affected as of 2024, representing 14% of the adult population (20-79 years). This burden is expected to increase by nearly 37% by 2050. Nearly 30% of adults with diabetes remain undiagnosed, signifying ongoing challenges in early detection and management. Impaired fasting glucose and impaired glucose tolerance, key signs of diabetes, affect millions, further driving nutritional intervention needs.

Clinical awareness and education programs are further contributing to the growth of the specialized nutrition market in Argentina by enhancing the understanding among healthcare professionals and patients of the importance of tailored nutrition in managing conditions such as malnutrition, oncology-related deficiencies, and metabolic disorders. These initiatives enhance clinical adoption, promote evidence-based nutrition practices, and increase consumer demand through public health campaigns and professional training, ultimately fostering greater acceptance and utilization of specialized nutrition products across healthcare and community settings.

Clinical Awareness & Education Programs in Argentina

These programs highlight Argentina’s commitment to advancing clinical nutrition knowledge through national congresses, multinational masterclasses, and innovative telehealth solutions. Such initiatives enhance healthcare professional awareness, equip practitioners with cutting-edge skills, and support the broader adoption of specialized nutrition as a cornerstone of patient care for chronic and critical conditions.

Market Concentration & Characteristics

The chart below illustrates the relationship between market concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, the impact of regulations, the level of partnership and collaboration activities, the degree of innovation, and regional expansion.

The degree of innovation in Argentina specialized nutrition industry is high, driven by the need to address disease-specific nutritional gaps, improve patient outcomes, and promote preventive healthcare. Companies are developing advanced formulations and functional ingredients tailored for conditions like diabetes, oncology, and pediatric care, while also expanding into plant-based and sustainable nutrition solutions. For instance, in July 2022, Danone launched the industry’s first Dairy & Plants Blend baby formula, a nutritionally complete product combining 60% high-quality, non-GMO soy protein with 40% dairy protein from casein and whey. Designed specifically for a vegetarian diet, this formula offers a mild plant flavor to gently introduce babies to plant tastes, supporting future healthy eating preferences.

“As a mother of four, I appreciate that parents want the very best nutrition for their baby’s healthy growth and development. At Danone, we also recognize that many parents want to introduce plant-based, vegetarian, and flexitarian options into their baby’s diet, while still meeting their baby’s specific nutritional requirements. Our new Dairy & Plants Blend baby formula has been developed with these needs top of mind.”

- Manuela Borella, Vice President, Global Plant-Based Strategy & Business Acceleration.

The level of partnerships and collaborations in Argentina specialized nutrition industry is moderate, focusing on expanding product accessibility, clinical validation, and consumer awareness. Companies are collaborating with healthcare institutions, research organizations, and local distributors to strengthen clinical evidence, promote education on condition-specific nutrition, and introduce innovative plant-based and fortified formulations tailored to regional dietary needs. For instance, in June 2023, Abbott and the American Diabetes Association (ADA) partnered to launch a therapeutic nutrition program designed to help people with diabetes manage their condition through personalized nutrition guided by continuous glucose monitoring (CGM) data.

Regulations have a strong impact on shaping Argentina specialized nutrition industry, as government agencies enforce strict standards on product formulation, labeling, and clinical claims to ensure safety and efficacy. Compliance with local food and health regulations, as mandated by bodies such as ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica), promotes product transparency and quality assurance, thereby driving consumer trust and market credibility. However, regulatory complexities and lengthy approval processes can also delay product launches, making compliance both a key growth enabler and an operational challenge for market players.

Route of Administration Insights

The oral segment led the market with the largest revenue share of 72.7% in 2024, driven by its ease of consumption, high patient compliance, and wide availability of specialized nutrition products in liquid, powder, and capsule forms. The segment benefits from strong demand in outpatient and home care settings, especially for managing chronic conditions and supporting preventive health.

The enteral segment is expected to witness at the fastest CAGR over the forecast years. The growing prevalence of cardiovascular and chronic diseases resulting from several metabolic disorders leads to difficulty in oral food consumption. It increases the preference for medical food feeding through the enteral mode. Moreover, the growing focus of the manufacturers to develop technologically advanced enteral feeding devices is positively impacting the segment growth.

Product Insights

The powder segment accounted for the largest market revenue share in 2024. Medical foods are most widely available in powder form, which can be administered through the oral route or enteral route by mixing milk or water, as advised by the physician. Medical foods in the powdered formula are suitable for patients of all age groups, especially in the oral route. Due to a high preference for powdered formulations, which offer ease of consumption, manufacturers are developing product categories in line with consumer preferences.

The liquid segment is anticipated to grow at the fastest CAGR during the forecast period, owing to the rising adoption of liquid formulations in the pediatric and geriatric population, where the intake of solid formulations is limited or impossible, and in cases of clinically diagnosed dysphagia or when oral physiology is limited.

Application Insights

The cancer segment accounted for the largest market revenue share in 2024, driven by the growing prevalence of oncology cases and the rising need for targeted nutritional support to manage treatment-related side effects and maintain patient strength. The increased clinical emphasis on nutrition therapy as part of comprehensive cancer care, combined with the availability of specialized formulations rich in protein and immune-supporting nutrients, has further boosted adoption within hospitals and oncology care centers in Argentina.

For instance, in January 2024, Danone partnered with digital oncology company Resilience to develop a nutrition support module integrated into Resilience’s digital oncology platform, enhancing care for cancer patients facing malnutrition. This collaboration combines Danone’s expertise in nutrition with Resilience’s patient monitoring and management tools, aiming to improve nutritional outcomes, support treatment adherence, and enhance quality of life for patients undergoing cancer treatment through evidence-based nutrition advice and screening tools.

The cachexia segment is expected to grow at the fastest CAGR over the forecast period, owing to the increasing incidence of chronic and debilitating diseases such as cancer, COPD, and heart failure, which often lead to severe muscle wasting and malnutrition. Rising clinical awareness of the role of specialized nutrition in managing cachexia, along with the development of high-calorie and protein-enriched formulations, is further supporting the segment’s steady growth in Argentina specialized nutrition industry.

Module Insights

The protein modules segment accounted for the largest market revenue share in 2024. Protein modules are utilized in severe infections, trauma, burns, malnutrition, post-surgical recovery, and for critically ill patients. The increasing prevalence of chronic diseases, such as cancer, chronic kidney disease, and malnutrition, which require specialized nutritional interventions, likely drives the segment growth. Patients undergoing treatments like chemotherapy or dialysis often suffer from muscle wasting and protein deficiencies, boosting demand for protein-enriched medical foods. In addition, the aging population, particularly in developed countries, further contributes to the need for protein modules to combat age-related muscle loss (sarcopenia).

The hypoallergenic module segment is expected to grow at the fastest CAGR over the forecast period. The growth is driven by the increasing prevalence of food allergies and intolerances, especially among infants and individuals with chronic health conditions. Hypoallergenic medical foods cater to patients with specific dietary needs, such as those who are unable to tolerate proteins found in common foods, like cow's milk or soy. These products are formulated to minimize allergic responses and are crucial for managing conditions such as severe food allergies, eosinophilic esophagitis, and gastrointestinal disorders. The rising awareness of food-related health issues and advancements in hypoallergenic formulations, such as amino acid-based or extensively hydrolyzed proteins, have significantly boosted demand.

Sales Channel Insights

The DTC segment led the market with the largest revenue share of 58.5% in 2024, driven by increasing consumer preference for convenient, home-based nutrition solutions and the rapid growth of e-commerce and digital health platforms in Argentina. Rising health awareness, along with the availability of personalized and plant-based nutrition products through online channels, is further propelling direct-to-consumer sales across the country.

The institutional sales segment is expected to grow at the fastest CAGR over the forecast period, driven by strong demand from hospitals, clinics, and long-term care facilities that rely on clinically validated nutrition products for patient recovery and disease management. Physician-led recommendations have further strengthened institutional procurement and ensured consistent product utilization across Argentina’s healthcare system.

Key Argentina Specialized Nutrition Company Insights

Key players in Argentina specialized nutrition industry is adopting innovative strategies, introducing condition-specific and plant-based formulations, and strengthening clinical collaborations to enhance product efficacy and accessibility. Companies are also focusing on local production, distribution partnerships, and awareness campaigns with healthcare professionals to expand market reach and address the growing demand for personalized and therapeutic nutrition solutions.

Performance of Key Brands by Value, Volume, And Sell-In & Sell-Out Trends Analysis (2022-2024)

Recent Developments

• In March 2025, Nutrisens announced its expansion into Latin America by acquiring a majority stake in Prodiet Medical Nutrition. This acquisition establishes Nutrisens as a strong local platform in Latin America and is expected to generate revenue synergies through cross-selling, innovation collaboration, and optimized sourcing and logistics.

• In May 2024, Danone acquired Functional Formularies, a leading US-based whole foods tube feeding company, as part of its Renew strategy. This acquisition expands Danone’s Medical Nutrition portfolio, enhancing its enteral tube feeding offerings with Functional Formularies’ unique, organic, and whole-food-based products, better positioning Danone to meet the nutritional needs of tube-fed patients and families.

“As a global leader in Medical Nutrition, we are delighted to welcome Functional Formularies to Danone. We are confident that with the addition of the greatly differentiated product portfolio of Functional Formularies, which complements our existing Real Food Blends branded range, we are even better positioned to support the nutritional needs of tube-fed families and patients.”

-Juergen Esser, Deputy CEO and CFO 

Argentina Specialized Nutrition Market Report Scope

Argentina Specialized Nutrition Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Argentina specialized nutrition market report based on route of administration, product, application, module, and sales channel.

• Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

  • Oral

  • Enteral

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Powder

  • Pills

  • Liquid

  • Other

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Chronic Kidney Disease

  • Minimal Hepatic Encephalopathy

  • Chemotherapy-Induced Diarrhea

  • Pathogen-Related Infections

  • Diabetic Neuropathy

  • ADHD

  • Depression

  • Alzheimer's Disease

  • Nutritional Deficiency

  • Orphan Diseases

    • Tyrosinemia

    • Eosinophilic Esophagitis

    • FPIES

    • Phenylketonuria

    • MSUD

    • Homocystinuria

    • Others

  • Wound Healing

  • Chronic Diarrhea

  • Constipation Relief

  • Protein Booster

  • Dysphagia

  • Pain Management

  • Parkinson's Disease

  • Epilepsy

  • Other Cancer related treatments

  • Severe Protein Allergy

  • Cancer

  • Cachexia

  • Other

• Module Outlook (Revenue, USD Million, 2021 - 2033)

  • Amino Acid Module

  • Protein Module

  • Vitamin & Mineral Modules

  • Fatty Acid-based Modules

  • Carbohydrate Modules

  • Fiber Modules

  • Ketogenic Modules

  • Peptide-based Modules

  • Hypoallergenic Modules

  • Others (Electrolyte Module, etc.)

• Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • DTC Sales Channel

    • Online Sales

    • Retail Sales

  • Institutional Sales

    • Hospitals

    • Others (Long-term Care Facilities, etc.)